Xuezhikang

DRUG4 trials

Sponsors

Wenzhou Medical University, Chinese Academy of Medical Sciences, Fuwai Hospital, Luye Pharma Group Ltd., Beijing Tsinghua Chang Gung Hospital

Conditions

DyslipidemiasHypertensionLipid Metabolism DisorderPrediabetic State (IGT)

Phase 1

Compare Pharmacokinetic(PK) Profiles of XZK vs Lovastatin in Healthy Male Volunteers

CompletedNCT02603770

Luye Pharma Group Ltd.Lipid Metabolism Disorder

Start: 2015-11-30End: 2016-02-29Updated: 2016-12-05

Phase 4

The Effect of XueZhiKang on Fatigue：Comparing With Simvastatin

CompletedNCT01686451

Wenzhou Medical UniversityDyslipidemias

Start: 2012-08-31End: 2013-09-30Updated: 2014-05-19

Effects and Underlying Mechanism of Lipid Lowering Intervention on Vascular Protection in Hypertensive Patients

Chinese Academy of Medical Sciences, Fuwai HospitalHypertension

Start: 2013-10-31End: 2016-10-31Target: 300Updated: 2014-10-02

The Effects of Xuezhikang and Atorvastatin on Lipid in Patients With Dyslipidemia and Prediabetes

RecruitingNCT06750783

Beijing Tsinghua Chang Gung HospitalPrediabetic State (IGT)

Start: 2024-12-31End: 2026-03-31Target: 398Updated: 2025-04-03

Related Papers

Red yeast rice induces less muscle fatigue symptom than simvastatin in dyslipidemic patients: a single center randomized pilot trial.

2017-05-189 citations